Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Trevi Therapeutics, Inc. | 160,000 | reported | 19 Feb 2026 | tx 18+908,463−218,876 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Feb 2026 | GRANT_AWARD | Trevi Therapeutics, Inc. | 160,000 | 0.00 USD | deriv |
| 31 May 2025 | GRANT_AWARD | Trevi Therapeutics, Inc. | 72,000 | 0.00 USD | deriv |
| 10 Mar 2025 | SALE | Trevi Therapeutics, Inc. | 4,350 | 7.15 USD | |
| 10 Mar 2025 | EXERCISE | Trevi Therapeutics, Inc. | 31,250 | 0.51 USD | |
| 10 Mar 2025 | EXERCISE | Trevi Therapeutics, Inc. | 63,813 | 3.91 USD | |
| 10 Mar 2025 | EXERCISE | Trevi Therapeutics, Inc. | 17,500 | 3.21 USD | |
| 10 Mar 2025 | SALE | Trevi Therapeutics, Inc. | 76,963 | 6.73 USD | |
| 10 Mar 2025 | EXERCISE | Trevi Therapeutics, Inc. | 63,813 | 0.00 USD | deriv |
| 10 Mar 2025 | EXERCISE | Trevi Therapeutics, Inc. | 17,500 | 0.00 USD | deriv |
| 10 Mar 2025 | GRANT_AWARD | Trevi Therapeutics, Inc. | 38,400 | 0.00 USD | deriv |
| 10 Mar 2025 | EXERCISE | Trevi Therapeutics, Inc. | 31,250 | 0.00 USD | deriv |
| 18 Feb 2025 | GRANT_AWARD | Trevi Therapeutics, Inc. | 225,500 | 0.00 USD | deriv |
| 15 Feb 2024 | GRANT_AWARD | Trevi Therapeutics, Inc. | 175,000 | 0.00 USD | deriv |
| 20 Jun 2023 | EXERCISE | Trevi Therapeutics, Inc. | 6,250 | 0.51 USD | |
| 20 Jun 2023 | EXERCISE | Trevi Therapeutics, Inc. | 6,250 | 0.00 USD | deriv |
| 07 Mar 2023 | EXERCISE | Trevi Therapeutics, Inc. | 18,750 | 0.51 USD | |
| 07 Mar 2023 | EXERCISE | Trevi Therapeutics, Inc. | 18,750 | 0.00 USD | deriv |
| 16 Feb 2023 | GRANT_AWARD | Trevi Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |